skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,749  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Material Type:
Article
Add to My Research

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503

Full text available

2
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

American journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]

2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415

Full text available

3
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

The New England journal of medicine, 2015-03, Vol.372 (13), p.1193-1203 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414264 ;PMID: 25692915

Full text available

4
Pharmacology of Corticosteroids for Diabetic Macular Edema
Material Type:
Article
Add to My Research

Pharmacology of Corticosteroids for Diabetic Macular Edema

Investigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.1-12 [Peer Reviewed Journal]

Copyright 2018 The Authors 2018 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22259 ;PMID: 29297055

Full text available

5
Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study
Material Type:
Article
Add to My Research

Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study

American journal of ophthalmology, 2015-07, Vol.160 (1), p.35-44.e1 [Peer Reviewed Journal]

Elsevier Inc. ;2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2015 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2015.04.021 ;PMID: 25896459 ;CODEN: AJOPAA

Full text available

6
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial

Archives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]

Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606

Full text available

7
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data
Material Type:
Article
Add to My Research

Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data

American journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]

2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAA

Full text available

8
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
Material Type:
Article
Add to My Research

Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

Eye (London), 2020-06, Vol.34 (Suppl 1), p.1-51 [Peer Reviewed Journal]

The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-020-0961-6 ;PMID: 32504038

Full text available

9
VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
Material Type:
Article
Add to My Research

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy

Annals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1089-1111 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2064541 ;PMID: 35451900

Full text available

10
Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy
Material Type:
Article
Add to My Research

Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Oxidative medicine and cellular longevity, 2017-01, Vol.2017, p.9702820-15 [Peer Reviewed Journal]

Copyright © 2017 Cheng Li et al. ;Copyright © 2017 Cheng Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2017 Cheng Li et al. 2017 ;ISSN: 1942-0900 ;EISSN: 1942-0994 ;DOI: 10.1155/2017/9702820 ;PMID: 28265339

Full text available

11
How to prevent the microvascular complications of type 2 diabetes beyond glucose control
Material Type:
Article
Add to My Research

How to prevent the microvascular complications of type 2 diabetes beyond glucose control

BMJ (Online), 2017-01, Vol.356 (8091), p.i6505-i6505 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i6505 ;PMID: 28096078

Full text available

12
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes
Material Type:
Article
Add to My Research

Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

British journal of ophthalmology, 2021-02, Vol.105 (2), p.216-221 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-315933 ;PMID: 32265201

Full text available

13
Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy
Material Type:
Article
Add to My Research

Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy

Investigative ophthalmology & visual science, 2020-02, Vol.61 (2), p.26-26 [Peer Reviewed Journal]

Copyright 2020 The Authors 2020 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.61.2.26 ;PMID: 32084272

Full text available

14
Retinal ganglion cells in diabetes
Material Type:
Article
Add to My Research

Retinal ganglion cells in diabetes

The Journal of physiology, 2008-09, Vol.586 (18), p.4401-4408 [Peer Reviewed Journal]

2008 The Authors. Journal compilation © 2008 The Physiological Society ;2008 The Authors. Journal compilation © 2008 The Physiological Society 2008 ;ISSN: 0022-3751 ;EISSN: 1469-7793 ;DOI: 10.1113/jphysiol.2008.156695 ;PMID: 18565995

Full text available

15
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Material Type:
Article
Add to My Research

Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time

Archives of ophthalmology (1960), 2022-10, Vol.140 (10), p.936 [Peer Reviewed Journal]

Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3130

Full text available

16
A review of anti-VEGF agents for proliferative diabetic retinopathy
Material Type:
Article
Add to My Research

A review of anti-VEGF agents for proliferative diabetic retinopathy

Eye (London), 2014-05, Vol.28 (5), p.510-520 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 2014 ;Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/eye.2014.13 ;PMID: 24525867

Full text available

17
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
Material Type:
Article
Add to My Research

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

Diabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2

Full text available

18
Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy
Material Type:
Article
Add to My Research

Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy

Archives of ophthalmology (1960), 2019-04, Vol.137 (4), p.363 [Peer Reviewed Journal]

Copyright American Medical Association Apr 2019 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2018.6399

Full text available

19
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
Material Type:
Article
Add to My Research

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy

Proceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (23), p.E3030-E3039 [Peer Reviewed Journal]

Volumes 1–89 and 106–112, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jun 9, 2015 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1423765112 ;PMID: 26039997

Full text available

20
Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy
Material Type:
Article
Add to My Research

Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy

American journal of ophthalmology, 2022-03, Vol.235, p.80-89 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.09.002 ;PMID: 34509431

Full text available

Results 1 - 20 of 1,749  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,642)

Refine My Results

Creation Date 

From To
  1. Before 1977  (26)
  2. 1977 To 1988  (46)
  3. 1989 To 2000  (70)
  4. 2001 To 2013  (575)
  5. After 2013  (1,033)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,745)
  2. Book Chapters  (3)
  3. magazinearticle  (1)
  4. More options open sub menu

Language 

  1. English  (1,689)
  2. Japanese  (266)
  3. Spanish  (27)
  4. Portuguese  (18)
  5. French  (17)
  6. German  (11)
  7. Norwegian  (2)
  8. Chinese  (2)
  9. Polish  (1)
  10. Russian  (1)
  11. Swedish  (1)
  12. Turkish  (1)
  13. Korean  (1)
  14. Czech  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait